Pharmacy Times

JULY 4, 2025

This single-center, retrospective, observational study included data from electronic health records and specialty pharmacies from January 1, 2023, to June 1, 2024, with specialty pharmacy dispensing data specifically used to identify patients who had received Humira and a biosimilar during the study period.

Specialty Pharmacies 86

Specialty Pharmacies Hospitals Compounding Pharmacies Vaccines 86

Pharmacy Times

JUNE 23, 2025

Additionally, ANDA submissions should extrapolate the RLD safety and effectiveness data for drugs with the same active ingredients, dosage forms, strengths, routes, and labeling. In the 505(j) ANDA approval pathway, on the other hand, submissions can be multisource generic drugs; however, this pathway requires bioequivalence to the RLD.

FDA 65

FDA Compounding Pharmacies Dosage Hospitals 65

Pharmacy Times

JULY 10, 2025

2 Guiding prescribers and patients through initiation of lumatperone, adjusting dosage amounts, and switching from other antipsychotics, emphasizing its favorable relapse reduction profile is key in preventing relapse.

FDA 50

FDA Hospitals Compounding Pharmacies Immunization 50

Pharmacy Times

JUNE 27, 2025

Generics are exact chemical copies of small-molecule drugs, with identical active ingredients, strengths, dosage forms, and routes of administration. Although generics and biosimilars offer lower-cost alternatives to brand-name drugs, they are not the same.

Compounding Pharmacies 50

Compounding Pharmacies FDA Immunization Hospitals 50

Pharmacy Times

JUNE 9, 2025

HME in drug manufacturing typically employs corotated twin extruders and uses heat and pressure to create solid dosage forms, dispersing the active pharmaceutical ingredient within a molten polymer matrix, and forming a solid solution or amorphous solid dispersion. trillion economic impact in 2020.

Compounding Pharmacies 73

Compounding Pharmacies Compounding Immunization FDA 73

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding 115

Compounding Compounding Pharmacies Patient Care Immunization 115

Pharmacy Times

JUNE 10, 2025

1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release.

FDA 73

FDA HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals 73

Pharmacy Times

JUNE 19, 2025

Trends Pharmacol Sci. 2024;45(5):406-418. doi:10.1016/j.tips.2024.03.004

Compounding 65

Compounding Compounding Pharmacies FDA Immunization 65

Pharmacy Times

JUNE 13, 2025

2 Vitamin D Immunity Vitamin D is a crucial hormone that supports bone health by facilitating the absorption of calcium and phosphorus, which is obtained mainly from sunlight exposure and food. Vitamin D is an accessible and inexpensive option compared to other drugs used to improve the response to chemotherapy.” P = 0.04).

Chemotherapy 141

Chemotherapy Immunization Compounding Pharmacies Hospitals 141

Pharmacy Times

JUNE 27, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 50

Compounding Pharmacies Immunization Chemotherapy Hospitals 50

Pharmacy Times

JULY 7, 2025

Limitations included open-label design and dosage constraints, but the multicountry approach enhanced generalizability and external validity. All patients underwent a 20-week correction period for dosage titration and Hb correction, which was followed by an 8-week evaluation for efficacy assessments. 1 REFERENCES 1.

Compounding Pharmacies 98

Compounding Pharmacies Dosage Labelling Immunization 98

Pharmacy Times

JULY 12, 2025

Animal studies reveal dose-dependent hepatic responses to CBD, supporting the need for cautious monitoring even at consumer-relevant dosages. Pharmacists should review patient medication profiles, advise on appropriate dosage adjustments, and monitor for cumulative toxicity. of healthy adults, necessitating liver function monitoring.

FDA 65

FDA Dosage Compounding Pharmacies Immunization 65

Pharmacy Times

JUNE 16, 2025

Steqeyma provides a new dosage form and strength, enhancing treatment flexibility for young patients with chronic inflammatory conditions. 2,3 Steqeyma, which was formerly known as CT-P43, is a human IL-12 and IL-23 antagonist indicated for multiple immune-mediated diseases.

FDA 104

FDA Compounding Pharmacies Immunization Vaccines 104

Pharmacy Times

JUNE 30, 2025

2,3 LIMBER is a phase 1, open-label, dose escalation study evaluating INCB057643 as a monotherapy at a dose escalation of 4 to 12 mg daily (part 1) or in combination with ruxolitinib at a dosage of 4 mg once daily and escalating to the maximum tolerated dose in part 1 (part 2).

Compounding Pharmacies 65

Compounding Pharmacies Compounding Immunization Specialty Pharmacies 65

Pharmacy Times

JUNE 18, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 73

Compounding Pharmacies Dosage Immunization Hospitals 73

Pharmacy Times

JUNE 16, 2025

The investigators assessed a total of 90 patients who received talquetamab at a dosage of 0.8 mg/kg once every 2 weeks plus teclistamab at a dosage of 3.0 2 As a combination therapy, talquetamab and teclistamab show significant promise in the phase 1b/2 dose escalation and expansion in the RedirecTT-1 trial (NCT04586426).

Compounding Pharmacies 50

Compounding Pharmacies Immunization Vaccines FDA 50

Pharmacy Times

JUNE 18, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 73

Compounding Pharmacies Dosage Immunization Hospitals 73

The Checkup by Singlecare

APRIL 30, 2024

Rinvoq (upadacitinib) is an oral prescription medication that belongs to a class of drugs called Janus kinase (JAK) inhibitors , which work by targeting specific pathways in the immune system to reduce inflammation. To use a Rinvoq coupon from SingleCare, choose your prescribed dosage, number of tablets, and preferred pharmacy.

Insurance 52

Insurance Insurance Coverage Health Insurance Companies Specialty Pharmacies 52

The Checkup by Singlecare

FEBRUARY 8, 2024

Rinvoq is classified in a group of drugs called Janus kinase inhibitors, or JAK inhibitors, and works by decreasing the activity of a specific part of the immune system. You may be required to purchase Rinvoq at a specialty pharmacy. The cost for a 30-day supply of Rinvoq, regardless of dosage, is $7,812 without insurance.

Insurance 52

Insurance Specialty Pharmacies Dosage Pharmaceutical Companies 52

The Checkup by Singlecare

APRIL 3, 2024

It is used to control inflammation by suppressing the immune system,” says Jelena Radan, Pharm.D. BCPS, Lead Clinical Pharmacy Specialist at KSP Specialty Pharmacy. If your prednisone dosage is once daily, consider taking the pills in the morning to reduce its likelihood of affecting your sleep.

Immunization 105

Immunization Specialty Pharmacies Dosage Labelling 105

The Checkup by Singlecare

SEPTEMBER 13, 2024

They are both injectable monoclonal antibodies that lessen the effects of interleukin-5 (IL-5), a key messenger within our immune system. Fasenra vs. Nucala: Key differences Both drugs work by preventing IL-5 from doing its job, namely signaling immune cells called eosinophils, which are partially responsible for asthma and allergies.

Labelling 52

Labelling Insurance Immunization Insurance Coverage 52

The Checkup by Singlecare

OCTOBER 15, 2024

Whether fighting infections, healing the body, or protecting it from germs, our immune systems have a lot of responsibility. However, they only apply for drugs you get from the pharmacy. Remicade (infliximab) is a tumor necrosis factor (TNF) blocker that’s approved to treat these conditions.

Insurance Coverage 52

Insurance Coverage Insurance Specialty Pharmacies Customer Service 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

Stelara works by blocking certain proteins called cytokines that trigger inflammation, specifically interleukin-12 and interleukin-23, helping to calm an overactive immune system and reduce symptoms of autoimmune conditions. Wezlana: Is there a difference? As biosimilars are defined, Wezlana is expected to be highly similar to Stelara.

FDA 52

FDA Vaccines Pharmaceutical Companies Specialty Pharmacies 52

The Checkup by Singlecare

APRIL 16, 2024

Stelara works by blocking proteins in the immune system that cause inflammation. Stelara as a treatment for psoriasis People with psoriasis have an overactive immune system. The subcutaneous dosage of Stelara for psoriasis is as follows: For adults with psoriasis who weigh 220 pounds or less: The first dose is 45 mg.

Dosage 98

Dosage Vaccines Immunization Insurance 98

The Checkup by Singlecare

AUGUST 6, 2024

Injection (intravenous infusion) Injection (intravenous infusion) What is the standard dosage? In some cases, Avsola and Remicade may be filled at a specialty pharmacy. According to the boxed warnings: Because they suppress the immune system, Avsola or Remicade may increase the risk of serious infections.

Vaccines 97

Vaccines FDA Insurance Insurance Coverage 97